Investigation of memory B cell response in asthmatic lungs.

Information

  • Research Project
  • 10303811
  • ApplicationId
    10303811
  • Core Project Number
    R21AI159456
  • Full Project Number
    1R21AI159456-01A1
  • Serial Number
    159456
  • FOA Number
    PA-20-195
  • Sub Project Id
  • Project Start Date
    6/1/2021 - 3 years ago
  • Project End Date
    5/31/2023 - a year ago
  • Program Officer Name
    DAVIDSON, WENDY F
  • Budget Start Date
    6/1/2021 - 3 years ago
  • Budget End Date
    5/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    5/27/2021 - 3 years ago

Investigation of memory B cell response in asthmatic lungs.

Project Summary/Abstract Allergic asthma is a chronic inflammatory disease of the lungs without cures and effective preventions. Allergen-specific IgE antibodies drive inflammation, airway constriction, and respiratory distress in patients with allergic asthma. Evidence for the existence of a local cellular source of pathogenic IgE in the airway is mounting. However, the precise identity of these cells as well as mechanisms for their localization within the asthmatic lung remain elusive. Using a mouse model of airway hypersensitivity, we have identified a lung- localized population of memory B cell that persists beyond the resolution of inflammation, but rapidly expands upon allergen re-challenge. We hypothesize that these cells are bona fide lung-resident memory B cells that elicit rapid local IgE responses and maintain long-term airway hypersensitivity. In this study, we will 1) elucidate the mechanisms that recruit MBCs and maintain their long-term tissue residency in asthmatic lungs using complementary immune phenotyping, single-cell transcriptomic and imaging analyses; and 2) investigate how functionally lung-resident MBCs contribute to allergic asthma using in vivo depletion of circulating memory B cells and adoptive transfer studies. This study on understanding the biology and functions of tissue-resident memory B cells in asthmatic lungs is imperative, and may reveal new targets for treating and preventing the progression of allergic asthma and other inflammatory lung conditions.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R21
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    150000
  • Indirect Cost Amount
    72973
  • Total Cost
    222973
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIAID:222973\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    LCMI
  • Study Section Name
    Lung Cellular, Molecular, and Immunobiology Study Section
  • Organization Name
    LOYOLA UNIVERSITY CHICAGO
  • Organization Department
    MICROBIOLOGY/IMMUN/VIROLOGY
  • Organization DUNS
    791277940
  • Organization City
    MAYWOOD
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    601533328
  • Organization District
    UNITED STATES